The damage caused by Alzheimer's disease begins long before any symptoms show up. Over the course of years or decades in this preclinical stage, the characteristic buildup of disease-causing amyloid ...
Alzheimer's disease is a kind of brain disease that progressively impairs thinking, behaviour, and memory. It is most prevalent in older adults, and people find it more difficult to carry out daily ...
Dementia is a broad term for memory loss and other cognitive issues, such as language and problem-solving problems, that can interfere with daily life. Alzheimer’s disease is one type of dementia.
Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in ...
In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.
Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...
Johnson & Johnson will discontinue the Phase II Auτonomy study of posdinemab after a scheduled review found the anti-tau ...
3dOpinion
Dr. Robert R. Redfield: We need an urgent and unified response to the coming Alzheimer’s crisis
In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a ...
Either we get ahead of the Alzheimer’s crisis or watch a generation swept into the devastating grip of disease, former CDC Director Dr. Robert R. Redfield writes in a Chicago Tribune ...
An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...
Today we begin a several-part series on Alzheimer’s disease, the most common cause of memory loss and dementia. Alzheimer’s is a brain disease characterized by amyloid plaques and neurofibrillary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback